Metal–organic frameworks as efficient materials for drug delivery: Synthesis, characterization, antioxidant, anticancer, antibacterial and molecular docking investigation
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Metal–organic framework (MOF) nano particles are a class of promising porous nano materials for biomedical applications. Owing to its high loading potential and pH‐sensitive degradation, most promising of the MOFs is the zeolitic imidazolate crystal framework (ZIF‐8), a progressive useful material for small molecule distribution. Doxorubicin (DOX), designated as a classical drug, was jobwise entrapped in ZIF‐8 nano particles. ZIF‐8 nano particles, as a novel carrier, were used to monitor the release of the anticancer drug DOX and prevent it from dissipating before reaching its goal. ZIF‐8 nano particles with encapsulated DOX (DOX@ZIF‐8) can be synthesized in a single pot by incorporation of DOX into the reaction mixture. MOFs and the designed drug delivery (DOX@ZIF‐8) system were characterized by Fourier transfer infrared, scanning electron microscopy, N 2 sorption isotherm and X‐ray diffraction. The impact of MOFs and the engineered drug delivery system on the viability of human breast and liver cancer cell lines was evaluated. The loaded drug was released at pH 5 faster than at pH 7.4. The nano particles of ZIF‐8 showed low cytotoxicity, while DOX@ZIF‐8 showed high cytotoxicity to HepG‐2 and MCF‐7 cells compared with free DOX at the equivalent concentration of DOX of >12.5 μg/ml. These findings indicate that DOX@ZIF‐8 nano particles are a promising method for the delivery of cancer cells to drugs. Furthermore, ZIF‐8, DOX and encapsulated DOX@ZIF‐8 compounds were screened for their potential antibacterial activities against pathogenic bacteria compared with standard antibiotics by the agar well diffusion technique. The results demonstrate that the DOX@ZIF‐8 exhibits a strong inhibition zone against Gram‐negative strains (Escherichia coli) in comparison with the reference drug gentamycin. The docking active site interactions were evaluated to predict the binding between DOX with the receptor of breast cancer 3hb5‐oxidoreductase and liver cancer 2h80‐lipid binding protein for anticancer activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kinetic Parameters from Thermogravimetric Data
COATS, A. W., & REDFERN, J. P. (1964) · Nature · doi:10.1038/201068a0 · Cited by 6,930
Controlled drug delivery vehicles for cancer treatment and their performance
Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-017-0004-3 · Cited by 2,167
Cited by
Pettinari, C., Pettinari, R., Di Nicola, C., Tombesi, A., Scuri, S., & Marchetti, F. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214121 · Cited by 329
Metadata
- Authors
- El‐Bindary, A. A., Toson, E. A., Shoueir, K. R., Aljohani, H. A., & Abo‐Ser, M. M.
- Venue
- Applied Organometallic Chemistry
- Publisher
- Wiley
- Published
- 2020-06-26
- Volume
- 34
- Issue
- 11
- ISSN
- 0268-2605 (ISSN-L)
- 1099-0739
- OpenAlex
- W3037489200
- Cited by
- 172
- References
- 2
- FWCI
- 13.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.